Phase 3 trial evaluating the immunogenicity, safety, and tolerability of manufacturing scale 13-valent pneumococcal conjugate vaccine

Title
Phase 3 trial evaluating the immunogenicity, safety, and tolerability of manufacturing scale 13-valent pneumococcal conjugate vaccine
Authors
Keywords
-
Journal
VACCINE
Volume 29, Issue 16, Pages 2947-2955
Publisher
Elsevier BV
Online
2011-02-17
DOI
10.1016/j.vaccine.2011.02.002

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation